Drug name - Qutenza

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10869827 AVERITAS Compositions and kits for the removal of irritating compounds from bodily surfaces Sep, 2023

(11 months from now)

US8263059 AVERITAS Compositions and kits for the removal of irritating compounds from bodily surfaces Sep, 2023

(11 months from now)

US8889113 AVERITAS Compositions and kits for the removal of irritating compounds from bodily surfaces Sep, 2023

(11 months from now)

US10463598 AVERITAS Compositions and kits for the removal of irritating compounds from bodily surfaces Sep, 2023

(11 months from now)

US10034841 AVERITAS Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer Sep, 2025

(2 years from now)

US9226903 AVERITAS Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer or the system and use of said back layer Dec, 2028

(6 years from now)

US8821920 AVERITAS Therapeutic patch for transdermal delivery of capsaicin Mar, 2030

(7 years from now)

Drugs and Companies using CAPSAICIN ingredient

Treatment: Method of using capsaicin in combination with a gel composition for removal of capsaicin from a treatment area or unintended area

Dosage: PATCH;TOPICAL

More Information on Dosage
Strength Dosage Availability
8% PATCH;TOPICAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.